Delivery Order SPE2DB22D3301-SPE2DB24FZ0UM
Award Date
7/17/24
Potential Completion Date
8/7/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract has a ceiling value of $3,311.50 and an ultimate completion date of September 20, 2024. The contract is a Firm Fixed Price type with no set-aside designation. AmerisourceBergen, through its Corporate Office Division, will provide the medical product to support the healthcare needs of military...
The U.S. Defense Logistics Agency (DLA) awarded a $3,311.50 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of Esbriet 801 mg tablets and has a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Esbriet 801 mg tablets. The total ceiling value of the contract is $3,311.50, and the ultimate completion date is October 11, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor responsible for providing these...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Esbriet 801 mg tablets to the Defense Logistics Agency (DLA). The $3,425.95 firm fixed price delivery order has a completion date of January 2, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $6,851.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply the medication Esbriet 801 mg tablet in quantities of 90s. The contract is a firm fixed-price, non-set-aside award with a completion date of May 20, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,851.90, is for the supply of Esbriet 267 mg capsules to support federal healthcare programs. The contract has a completion date of March 20, 2025 and is a firm-fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of Esbriet 267 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of 4568189215 ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on May 30, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esbriet 267 mg tablets, a medication used to treat a specific medical condition. The contract has a ceiling value of $6,851.90 and is a firm fixed-price delivery order, with a performance period ending on May 22, 2025. The contract is not set-aside and was awarded on May 1,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $6,851.90 and a completion date of June 5, 2025. The contract is not set aside and was awarded on May 14, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a...